Quarterly Result5 Feb 2026, 01:37 pm
Jubilant Ingrevia Q3'FY26 Results: Revenue Up 3%, EBITDA Rises 8%, PAT Grows 8%
AI Summary
Jubilant Ingrevia Limited reported its financial results for the quarter ended December 31, 2025. The company's Speciality Chemicals segment fueled growth momentum, delivering revenue expansion and a robust double-digit increase in EBITDA. The Nutrition business sustained a healthy trajectory of volume growth. The Chemical Intermediates segment maintained its market share while recording year on year volume growth. The company announced an interim dividend of 250%.
Key Highlights
- Speciality Chemicals segment delivered revenue expansion and a robust double-digit increase in EBITDA
- Nutrition business sustained a healthy trajectory of volume growth
- Chemical Intermediates segment maintained market share and recorded year on year volume growth
- Company announced an interim dividend of 250%
- Company demonstrated resilience and strength in navigating challenging market conditions